Maija Saraste
maihel@utu.fi +358 29 450 4743 +358 50 472 8266 Itäinen Pitkäkatu 4 Turku |
- Association between post-COVID-19 neuropsychiatric symptoms and persistent glial activation in the limbic system: a TSPO PET study (2026)
- Journal of Neurology
- TSPO-PET-measurable neuroinflammation associates with information processing speed decline in multiple sclerosis (2026)
- Multiple Sclerosis
- Multiple sclerosis: 2024 update (2025)
- Free Neuropathology
- Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis (2025)
- Journal of Neurology, Neurosurgery and Psychiatry
- Predictors of risk of secondary progression in multiple sclerosis (2025)
- Therapeutic Advances in Neurological Disorders
- Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brain (2025)
- Therapeutic Advances in Neurological Disorders
- A Novel Comprehensive Epigenomic Liquid Biopsy Assay Reveals Disease Biology in Multiple Sclerosis Patients from 1 mL of Plasma (2024)
- Multiple Sclerosis
- Plasma CHI3L1 associates with increased TSPO-PET measurable microglial activation in patients with progressive multiple sclerosis (2024)
- Multiple Sclerosis
- Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals (2024)
- Frontiers in Neurology
- TSPO-PET-measurable microglial activity remains unaltered in cladribine-treated RRMS patients (2024)
- Multiple Sclerosis



